• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC. MYOSURE REACH HYSTEROSCOPIC TISSUE REMOVAL SYSTEM; UTERINE TISSUE REMOVAL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC. MYOSURE REACH HYSTEROSCOPIC TISSUE REMOVAL SYSTEM; UTERINE TISSUE REMOVAL SYSTEM Back to Search Results
Model Number 10-401FC
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Uterine Perforation (2121); Bowel Perforation (2668)
Event Date 02/09/2019
Event Type  Injury  
Manufacturer Narrative
Lot and serial number of the disposable device not provided by the complainant, therefore the expiration date is not known.The device has not yet been returned therefore, a failure analysis of the complaint device cannot be completed.Lot number of the disposable device not provided by the complainant, therefore the manufacture date is not known.Device history record (dhr) review and sterile lot review were unable to be conducted for the disposable device as the lot number was not provided by the complainant.Internal complaint reference: (b)(4).
 
Event Description
It was initially reported that during the use of a myosure tissue removal device that a uterine perforation and bowel resection occurred.The patient was rushed to the hospital for emergency surgery.Additional information obtained noted that for hysteroscopic fluid distention saline was used from an iv bag with a blood pressure cuff, along with wall suction for outflow.Ultrasound guidance was employed during the procedure.The fibroid was noted to have an intramural component, located on the lateral sidewall, approximately 2.5cms.After noting adequate visualization with hysteroscopy the myosure device was inserted and the physician then experienced difficulty visualizing the cavity.To improve the visual field the physician inserted the device further into the cavity while activating the cutting mechanism of the myosure.The visual field was still not cleared, but it became apparent that a uterine perforation had occurred.Further investigation revealed a perforation of the small bowel requiring resection and primary anastomosis.The fluid deficit was 1 liter.
 
Manufacturer Narrative
As of today the reported device has not been returned for evaluation.If the device is returned a follow up will be filed as needed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYOSURE REACH HYSTEROSCOPIC TISSUE REMOVAL SYSTEM
Type of Device
UTERINE TISSUE REMOVAL SYSTEM
Manufacturer (Section D)
HOLOGIC, INC.
250 campus drive
marlborough MA 01752
MDR Report Key8404036
MDR Text Key138246147
Report Number1222780-2019-00049
Device Sequence Number1
Product Code HIH
Combination Product (y/n)N
PMA/PMN Number
K152723
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 02/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number10-401FC
Device Catalogue Number10-401FC
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/11/2019
Initial Date FDA Received03/08/2019
Supplement Dates Manufacturer Received02/11/2019
Supplement Dates FDA Received04/25/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
-
-